Protalix BioTherapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Protalix BioTherapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.03 USD/shares, a 110% decline year-over-year.
  • Protalix BioTherapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.21 USD/shares, a 333% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Earnings Per Share, Basic for 2023 was 0.12 USD/shares.
  • Protalix BioTherapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.31 USD/shares, a 50% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -0.62 USD/shares, a 182% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0.12 +$0.43 Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $0 +$0.31 +50% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$1 $0 -182% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $0 +$1.01 +82.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$1 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.